WebJan 29, 2024 · Green Cross Labcell joins US$1.8 bln deal to develop cancer drug. SEOUL, Jan. 29 (Yonhap) -- A subsidiary of South Korean pharmaceutical firm Green Cross Corp. said Friday it has participated in a partnership deal worth US$1.8 billion to develop natural killer (NK) cell therapies to treat cancer. WebFeb 26, 2024 · Existing investors, 5AM Ventures, RA Capital Management, and venBio Partners, along with strategic partners GC LabCell (Green Cross LabCell Corporation, KRX: 14451) and GC (Green Cross Holdings Corporation, KRX: 005250), also participated in the financing. Artiva plans to use the proceeds from the financing to advance its NK …
GC Cell
WebSep 4, 2024 · Green Cross LabCell Corporation . 107, Ihyeon-ro 30 beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 446-850, 16924, Republic of South Korea. Attention: Chief Executive Officer . With a copy (which shall not constitute … sma wma holt linear regression seasonal
GC Cell Obtains Anti-bribery Management System Certification
WebMaster Research Services Agreement, dated August 3, 2024, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2024) Selected Product License Agreement (AB-101), dated November 21, 2024, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2024) WebWelcome into our Green Cross laboratory network, please do log and explore more … WebApr 6, 2024 · GC Cell is an integrated corporation created through the recent merger of Green Cross Labcell and Green Cross Cell and focuses on the development and production of treatments using immune cells and stem cells. In particular, it has a variety of pipelines for autologous and allogeneic cell therapies. It also has global competitiveness … high waisted velvet mini skirt